17th Clinical Trials on Alzheimer’s Disease conference (CTAD)

• 17th Clinical Trials on Alzheimer’s Disease conference (CTAD)
• October 29 – November 1
• Madrid Marriott Auditorium Hotel & Conference Center Avda. de Aragón 400 - 8022 Madrid, SPAIN Madrid, Spain.
• CTAD Alzheimer Congress | 16th Clinical Trials on Alzheimer's Disease (ctad-alzheimer.com)

On October 24-27, 2023 CTAD23 attracted over 2,250 international leaders to discuss the future of Alzheimer’s disease clinical research with pivotal readouts from major pharmaceutical companies and new avenues of treatment beyond Amyloid and Tau.

At CTAD 2024, the scientific program will again focus on bringing cutting edge clinical research, thought-provoking roundtable and symposia on the latest advances in AD clinical research. CTAD 2024 brings together leaders from academic research centers, patient advocacy groups, international research coalitions and pharmaceutical companies.

The CTAD scientific program is based on a strict peer-review abstract selection process. CTAD 2024 is a great opportunity for clinical and research teams around the world to showcase their work in AD clinical trials.

In this edition, the director of the CIEN Foundation, Pascual Sánchez-Juan will be part of the CTAD National Organising Committee, who will participate in the Welcome Ceremony and will moderate one of the oral communication sessions.

Check the programme to make sure you don't miss this and the posters presented by CIEN Foundation researchers: https://www.ctad-alzheimer.com/files/files/ProgramPrel_CTAD2024_4sept.pdf